Conduit Pharmaceuticals (CDT) Q3 2025 Earnings

Screener

Reported November 13, 2025 · Before market open

EPS-$13.16

Next report

Date not yet announced

Versus estimates

Revenue

Q2 2026$750.2M Q1 2026$696.4M

Diluted EPS

Q2 2026-$8.71 Q1 2026-$5.56 Q4 2025-$99.99

Q3 2025-$13.16

Q2 2025-$43.68 Q1 2025-$158.32

FAQ

When did Conduit Pharmaceuticals report Q3 2025 earnings?: Conduit Pharmaceuticals (CDT) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Conduit Pharmaceuticals's Q3 2025 revenue and EPS?: Conduit Pharmaceuticals reported eps of $-13.16 for Q3 2025.
How did Conduit Pharmaceuticals's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, eps grew 98.4% from $-839.58.
Where can I find Conduit Pharmaceuticals's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0001493152-25-022373) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Conduit Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk